Countries North America

LOTTE Biologics and Alvotech Forge Long-Term Partnership to Expand Global Biosimilar Manufacturing Capacity

Collaboration covers multiple biosimilar products to be manufactured at LOTTE Biologics' Syracuse facility in New York Strategic long-term partnershi...

 October 13, 2026 | News

Nuevocor Doses First Patient in Phase 1/2 Gene Therapy Trial for Inherited Cardiomyopathy

 Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening...

 October 13, 2026 | News

SOPHiA GENETICS, Myriad Genetics and AstraZeneca Collaborate to Advance Precision Oncology in Prostate Cancer

SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN)  announce a collaboration to advance new prostate cancer-specific genomi...

 October 13, 2026 | News

Rockwell Automation Joins Digital CMC Consortium to Accelerate Drug Development and Pharmaceutical Manufacturing

Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, announced it is a fo...

 October 13, 2026 | News

Innovent’s SYCUME Meets Primary Endpoint in Phase III Trial for Inactive Thyroid Eye Disease in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

 October 12, 2026 | News

Quanterix and Innovita Secure China Regulatory Approvals for SIMOA-Based Alzheimer's Disease Biomarker Tests

Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., Ltd. (SSE: 688253.SH), a lead...

 October 09, 2026 | News

Resonant Clinical Solutions and Haier Biomedical Launch Eco-Friendly Centrifuge for Clinical Trials

Resonant Clinical Solutions – a global clinical solutions partner serving life sciences organizations across the clinical supply chain and sample lif...

 October 09, 2026 | News

XtalPi Launches AI-Powered Kodexia Platform to Accelerate siRNA Drug Discovery

This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property...

 October 08, 2026 | News

Celaid Therapeutics Raises $2.6M to Advance CLD-001 Towards US Clinical Trials

Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate U.S. Clinical Trial Preparations for CLD-001 Celaid Therapeutics Inc...

 October 06, 2026 | News

FDA Expands Lilly’s Jaypirca Approval to First-Line CLL/SLL Treatment

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirto...

 October 06, 2026 | News

Genmab’s Rina-S Shows Durable Response in Platinum-Resistant Ovarian Cancer

Treatment with Rina-S® 120 mg/m² every three weeks demonstrated a clinically meaningful objective response rate (ORR) and durable median durat...

 October 06, 2026 | News

CJ CheilJedang, ADM Form Amino Acid JV to Strengthen Supply in Americas

Proposed joint venture will manufacture and market amino acids critical to the livestock industry, supporting U.S. production, strengthening the global...

 October 05, 2026 | News

Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

 October 05, 2026 | News

Piramal and NP2 Advance Generic Cancer Drug Cyclophosphamide Towards US Manufacturing

Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturi...

 October 02, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close